We are closed from December 28th PM(Sat) until January 4th (Fri).
From October 1st, 2019, ｗe will charge 20 JPY per national healthcare
point for all foreign patients who do not have Japanese National Health Insurance.
We will give you a prescription that can be taken to a pharmacy outside of the clinic.
Thank you for your understanding and cooperation.
The consultation charge (pre LASIK/SMILE/ICL/Orthokeratology) for the patients who could NOT speak English or Japanese will be 20,000 JPY from January 2019.
The free trial examination will close by the end of the year.
We will charge 3,000 JPY for the orthokeratology examination from January 2019. The rental charge of the trial lens will be free.
Quality of Vision
In 1997, the Minamiaoyama Eye Clinic, which was the first refractive surgery center operated by board-certified ophthalmologists, began performing refractive surgeries. This type of surgery was not popular in Japan at the time our clinic was established.
In order to provide more vision correction options for our patents, we aimed at establishing a refractive surgery
clinic that can provide high quality treatment by doctors specialized in ophthalmology and refractive surgery.
We have introduced various refractive techniques over the past 20 years, including LASIK, custom (wavefront-guided or topography-guided) LASIK, Phakic IOL, PRK, LASEK,
refractive diffractive multifocal IOL, presbyopic surgery, conductive keratoplasty (CK) , intrastromal ring segments (ICRS), riboflavin/UVA cross-linking, and corneal transplantation for keratoconus.
Although we have occasionally encountered some difficulties during the initial application of new technologies, we are very happy to provide corrective options to people with a wide range of refractive errors.
We collected patient data using a good filing system. A large number of our patients return for postoperative follow-up even long after their LASIK surgery has been performed.
We believe that these data are crucial as feedback to our medical practice.
We would like to continue providing evidence-based treatment by constantly learning from our patients.